Institutes of Biomedical Research Corp (MRES)

[stocklock]

GREAT NEWZ, NEURO IN 'INTERNATIONAL BUSINESS TIMES'

http://www.ibtimes.com/articles/60665/20100908/neuro-biotech-corp-mres-pk-is-one-to-watch.htm


ONE TO WATCH

Neuro-Biotech Corp.’s has shifted their focus from mining operations to the realm of neuroscience. Neuro-Biotech Corporation is working to become a worldwide leader in the field of clinical applied-neuroscience related to stress management and mental health for prevention, early diagnosis and therapeutic follow-up. Neuro-Biotech Corp.’s headquarters are in Basel, Switzerland.


The Company is a neuroscience medical diagnostic enterprise involved in the unique international niche of clinical neuroscience. Their emphasis is on rapidly developing and commercializing innovative and competitive diagnostic products, with the goal of becoming a world leader in this market.

As a result of years of study, Neuro-Biotech Corp. has discovered how, following a stressful event, the body’s three systems (Endocrine, Nervous and Immune) work together to protect the body through the HPAS Axis. The foundation of all Neuro-Biotech Corp. activities is based on this unique communication pathway.

Neuro-Biotech’s vision is to be the first neuro-pharmaceutical company to bring to market analytical diagnostic products specifically designed to facilitate early diagnosis and monitoring. This will allow follow-up treatments via a targeted therapeutic approach to the major psycho-social environmental diseases related to the neuro-psycho-endocrine and immune systems.


Earlier this year, the Company signed 16 worldwide license agreements exclusively for the manufacturing and distribution of two groups of products. The first is an innovative portfolio of quantitative “in vitro” diagnostic kits. These offer easy detection of various molecules released within the blood of subjects suffering from stress and neuroscience — related disorders.

The second group of products is natural brain adaptogene products — called Neuroceuticals™. These are specifically designed to stimulate targeted neurotransmitters and provide health benefit effects. These are ready to be introduced to the market.

Neuro-Biotech Corp.’s goals are to develop and commercialize quantitative diagnostic blood tests for early diagnosis, monitoring and follow-up for a large range of neuroscience and stress related disorders. This is to accommodate unsatisfied medical needs and develop their own extensive portfolio of diagnostic tests and natural brain neuroceuticals.

They are also looking to enter into strategic alliances with large distributors to accelerate their worldwide market penetration in general and, in particular, some revenue interesting niche markets, by initiating sales through their own sales force, and by forming business partnerships with private laboratory networks on a global basis.